1. 1) Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur. J. Haematol., 80, 185–196 (2008).
2. 2) Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, Miyamoto K, Sato J. A novel T-cell line derived from adult T-cell leukemia. Gann, 71, 155–156 (1980).
3. 3) Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukaemic T cells. Nature, 294, 770–771 (1981).
4. 4) Nakano D, Ishitsuka K, Hatsuse T, Tsuchihashi R, Okawa M, Okabe H, Tamura K, Kinjo J. Screening of promising chemotherapeutic candidates against human adult T-cell leukemia/lymphoma from plants: active principles from Physalis pruinosa and structure–activity relationships with withanolides. J. Nat. Med., 65, 559–567 (2011).
5. 5) Nakano D, Ishitsuka K, Katsuya H, Kunami N, Nogami R, Yoshimura Y, Matsuda M, Kamikawa M, Tsuchihashi R, Okawa M, Ikeda T, Nohara T, Tamura K, Kinjo J. Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (II): apoptosis of antiproliferactive principle (24,25-dihydrowithanolide D) against ATL cell lines and structure–activity relationships with withanolides isolated from solanaceous plants. J. Nat. Med., 67, 415–420 (2013).